Cancer Proteomics, Berlin, Germany

Select Biosciences will be holding its 3rd Annual Cancer Proteomics conference, co-located with the inaugural Antibody and Peptide Therapeutics conference, in the exciting city of Berlin. This will be an opportunity for delegates to catch up with the latest developments in cancer diagnosis, therapeutics and prevention, using arrays as well as biomarker discovery through proteomics.

Further Information: http://www.cancerproteomics.net